Saturday 22 Feb, 2025 12:34 PM
Site map | Locate Us | Login
   ICRA downgrades ratings of Fusion Finance to 'A-' with 'negative' outlook    Bharti Airtel board OKs to acquire additional 5% stake in Airtel Africa    Jio Financial, Zomato to become part of Nifty 50 index    Lupin gets EIR from USFDA for New Jersey facility    Granules India's board OKs to acquire 100% stake in Senn Chemicals AG    Agarwal Industrial bags bitumen supply contract from BPCL    Pfizer partners with Mylan for marketing of Ativan and Pacitane    One MobiKwik to acquire 3.39% stake in Blostem Fintech    Religare Enterprises surges after Burman Family secures majority control    Mahindra & Mahindra Ltd leads losers in 'A' group    FCS Software Solutions Ltd leads losers in 'B' group    DEV IT jumps on bagging order from Rajya Sabha Secretariat    Volumes jump at Godrej Industries Ltd counter    Consumer goods stocks edge lower    Healthcare shares fall 
Saravan Stocks
       
Company News
Eicher Motors Ltd
Stock Alert: Eicher Motors, Grasim Inds, Nykaa, Apollo Hospital Enterprise
Feb 11,2025   Hrs IST

Securities in F&O ban:

Manappuram Finance shares are banned from trading in F&O on Tuesday, 11 February 2025.

Earnings Today:

Ashiana Housing, Astrazeneca Pharma India, Awfis Space Solutions, Bayer Cropscience, Berger Paints India, BLS International Services, Birlasoft, Campus Activewear, Cello World, Cera Sanitaryware, Dalmia Bharat Sugar and Industries, Devyani International, EID-Parry (India), EIH, EPL, Gensol Engineering, Gujarat Alkalies & Chemicals, HEG, Huhtamaki India, Indo Count Industries, Vodafone Idea will declare their quarterly earnings later today.

Stocks to Watch:

Eicher Motors’ consolidated net profit jumped 17.5% to Rs 1,170.50 crore in Q3 FY25 as compared with Rs 995.97 crore in Q3 FY24. Net sales increased 18.8% YoY to Rs 4,888.11 crore.

Grasim Industries' consolidated net profit declined 40.6% to Rs 898.97 crore in Q3 FY25 as against Rs 1,514.44 crore in Q3 FY24. Net sales increased 8.8% YoY to Rs 34,792.85 crore in Q3 FY25.

Apollo Hospitals Enterprise’s consolidated net profit jumped 51.8% to Rs 372.30 crore on 13.9% increase in net sales to Rs 5,526.90 crore in Q3 FY25 over Q3 FY24.

Bata India’s consolidated net profit rose 1.2% to Rs 58.70 crore in Q3 FY25 as compared with Rs 57.98 crore in Q3 FY24. Net sales increased 1.7% YoY to Rs 918.79 crore in Q3 FY25.

FSN E-Commerce (Nykaa) reported 61.3% jump in consolidated net profit to Rs 26.12 crore in Q3 FY25 as compared with Rs 16.19 crore in Q3 FY24. Net sales increased 26.7% YoY to Rs 2,267.21 crore during the quarter.

Lupin has received approval from US Food and Drug Administration (USFDA) for its abbreviated drug application for Ipratropium Bromide Nasal Solution.

Shriram Properties has entered into joint development agreement (JDA) to develop prime land at Koyamedu, Chennai. The company is embarking on developing a premium residential complex with an aggregate saleable area of 3.2 lakh sqft, to be developed over the next 3 years. The project is expected to have aggregate revenue potential of approximately Rs 350 – Rs 400 crore and is being targeted for launch during early FY26.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 39051851
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd